Potential impact of rotavirus vaccination on the mortality of children in developing countries

  • Duncan Steele
Part of the Birkhäuser Advances in Infectious Diseases book series (BAID)


The global burden of rotavirus infection and associated mortality in infants and young children has led to the international prioritization of the development of a rotavirus vaccine. In recent months, two new rotavirus vaccines have been licensed by the multinational pharmaceutical industry and are currently being introduced into routine childhood immunization schedules in the Americas and Europe. However, for the full impact of these rotavirus vaccines to be felt they need to be introduced into Africa and Asia where the bulk of rotavirus associated mortality occurs. Several questions regarding the efficacy of the vaccines in these settings remain, as well as questions of supply and pricing of the vaccines.


Oral Poliovirus Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Black RE, Morris SS, Bryce J (2003) Where and why are 10 million children dying every year? Lancet 361: 2226–2234CrossRefPubMedGoogle Scholar
  2. 2.
    Kosek M, Bern C, Guerrant RL (2003) The global burden of diarrheal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 81: 197–204PubMedGoogle Scholar
  3. 3.
    UN Millennium Development Goals. www.unmillenniumproject.orgGoogle Scholar
  4. 4.
    World Health Organization (1999) Rotavirus vaccines: WHO Position Paper. Wkly Epidemiol Rec 74: 3–38Google Scholar
  5. 5.
    Parashar U, Gibson CJ, Bresee JS, Glass RI (2005) Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12: 304–306Google Scholar
  6. 6.
    Glass RI, Parashar U, Bresee JS, Turcois R, Fischer TK, Widdowson MA, Jiang B, Gentsch J (2006) Rotavirus vaccines: Current prospects and future challenges. Lancet 368: 323–332CrossRefPubMedGoogle Scholar
  7. 7.
    Bresee JS, Glass RI, Ivanoff B, Gentsch J (1999) Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 7: 2207–2222CrossRefGoogle Scholar
  8. 8.
    Parashar U, Hummelman EG, Bresee JS, Miller MA, Glass RI (2003) Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9: 565–572PubMedGoogle Scholar
  9. 9.
    Cunliffe NA, Kilgore PE, Bresee JS, Steele AD, Luo N, Hart CA, Glass RI (1998) Epidemiology of rotavirus diarrhea in Africa: A review to assess the need for rotavirus immunization. Bull World Health Organ 76: 525–537PubMedGoogle Scholar
  10. 10.
    Steele AD and Ivanoff B (2003) Rotavirus strains circulating in Africa. The emergence of G9 and P[6] strains. Vaccine 21: 361–367CrossRefPubMedGoogle Scholar
  11. 11.
    Bresee J, Fang ZY, Wang B, Nelson EA, Tam J, Soenarto Y, Wilopo SA, Kilgore P, Kim JS, Kang JO et al (2004) First report from the Asian Rotavirus Surveillance Network. Emerg Infect Dis 10: 988–995PubMedGoogle Scholar
  12. 12.
    Kane EM, Turcios R, Arvay ML, Garcia S, Bresee JS, Glass RI (2004) The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Rev Panam Salud Publica 16: 371–377CrossRefPubMedGoogle Scholar
  13. 13.
    Soriano-Gabarro M, Mrukowicz J, Vesikari T, Verstraeten T (2006) Burden of rotavirus disease in the European Union countries. Pediatr Infect Dis J 25: S7–S11CrossRefPubMedGoogle Scholar
  14. 14.
    Ruiz-Palacios GM, Perez-Schael I, Velasquez R, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL et al (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354: 11–22CrossRefPubMedGoogle Scholar
  15. 15.
    Vesikari T, Matson DO, Dennehy P, Dallas MJ, DiStefano DJ, Goveia MG, Ward RL, Schodel F, Karvonen A, Drummond JE et al (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354: 23–33CrossRefPubMedGoogle Scholar
  16. 16.
    Parashar U, Holman RC, Clarke MJ, Bresee JS, Glass RI (1997) Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: Surveillance based on new ICD-9-CM rotavirus specific diagnostic code. J Infect Dis 177: 13–17CrossRefGoogle Scholar
  17. 17.
    Rheingans RD, Heylen J, Giaquinto C (2006) Economics of rotavirus gastroenteritis and vaccination in Europe. What makes sense? Pediatr Infect Dis J 25: S48–S55CrossRefPubMedGoogle Scholar
  18. 18.
    Kapikian AZ, Hoshino Y, Chanock RM (2001) Rotaviruses. In: DM Knipe, PM Howley, DE Griffin, RA Lamb, MA Martin, B Roizman, SE Strauss (eds): Fields Virology, 4th edn. Lippincott, Williams and Wilkins, Philadelphia, 1787–1833Google Scholar
  19. 19.
    World Health Organisation (2000) Report of the meeting on the Future Directions for Rotavirus Research in Developing Countries. World Health Organisation, Geneva. WHO/V&B/.00.23 Google Scholar
  20. 20.
    Bresee JS, Hummelman E, Nelson EAS, Glass RI (2005) Rotavirus in Asia: The value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis 192: S1–S5CrossRefPubMedGoogle Scholar
  21. 21.
    Fang ZY, Yang H, Zhang J, Li YF, Hou AC, Ma L, Sun LW, Wang CX (2000) Child rotavirus infection in association with acute gastroenteritis in two Chinese sentinel hospitals. Pediatr Int 42: 401–405CrossRefPubMedGoogle Scholar
  22. 22.
    Fischer TH, Valentiner-Branth P, Steinsland H, Perch M, Santos G, Aaby P, Molbak K, Sommerfelt H (2002) Protective immunity after natural rotavirus infection: A community cohort study of newborn children in Guinea Bissau, West Africa. J Infect Dis 186: 593–597CrossRefPubMedGoogle Scholar
  23. 23.
    Nguyen VM, Nguyen VT, Huynh PL, Dang DT, Nguyen TH, Phan VT, Nguyen TL, Le TL, Ivanoff B, Gentsch JR et al (2001) The epidemiology and disease burden of rotavirus in Vietnam: Sentinel surveillance at 6 hospitals. J Infect Dis 183: 1707–1712CrossRefPubMedGoogle Scholar
  24. 24.
    Steele AD, Peenze I, De Beer MC, Pager CT, Yeats J, Potgieter N, Ramsaroop U, Page NA, Mitchell JO, Geyer A et al (2003) Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa. Vaccine 21: 354–360CrossRefPubMedGoogle Scholar
  25. 25.
    Bishop RF (1996) Natural history of human rotavirus infections. In: AZ Kapikian (ed): Viral Infections of the Gastrointestinal Tract, 2nd edn. Marcel Dekker, New York, 131–167Google Scholar
  26. 26.
    Bishop RF, Barnes GL, Cipriani E, Lund JS (1983) Clinical immunity after neonatal rotavirus infection: A prospective longitudinal study in young children. N Engl J Med 309: 72–76PubMedCrossRefGoogle Scholar
  27. 27.
    Dearlove J, Latham P, Dearlove B, Pearl K, Thomson A, Lewis IG (1983) Clinical range of neonatal rotavirus infection. Br Med J 286: 1473–1475CrossRefGoogle Scholar
  28. 28.
    Hoshino Y, Wyatt RG, Flores J, Midthun K, Kapikian AZ (1985) Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections. J Clin Microbiol 21: 425–430PubMedGoogle Scholar
  29. 29.
    Cook SM, Glass RI, Le Baron CW, Ho MS (1990) Global seasonality of rotavirus infections, Bull World Health Organ 68: 171–177PubMedGoogle Scholar
  30. 30.
    Bhan MK, Lew JF, Sazawal S, Das BK, Gentsch JR, Glass RI (1993) Protection conferred by neonatal rotavirus infection against subsequent diarrhea. J Infect Dis 168: 282–287PubMedGoogle Scholar
  31. 31.
    Velazquez FR, Matson DO, Calva JJ, Guerrero ML, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacois GM (1996) Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 335: 1022–1028CrossRefPubMedGoogle Scholar
  32. 32.
    Estes MK (2001) Rotaviruses and their replication. In: DM Knipe, PM Howley, DE Griffin, RA Lamb, MA Martin, B Roizman, SE Strauss (eds): Fields Virology, 4th edn. Lippincott, Williams and Wilkins, Philadelphia, 1747–1785Google Scholar
  33. 33.
    Hoshino Y, Sereno MM, Midthun K, Flores J, Kapikian AZ, Chanock RM (1985) Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of the rotavirus infectivity. Proc Natl Acad Sci USA 82: 8701–8704CrossRefPubMedGoogle Scholar
  34. 34.
    Hoshino Y, Wyatt RG, Greenberg HB, Flores J, Kapikian AZ (1984) Serotypic similarity and diversity among rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis 149: 694–702PubMedGoogle Scholar
  35. 35.
    Gentsch JR, Woods PA, Ramachandran M, Das BK, Leite JP, Alfieri A, Kumar R, Bhan MK, Glass RI (1996) Review of G and P typing results from a global collection of rotavirus strains; implications for vaccine development. J Infect Dis 174: 530–536Google Scholar
  36. 36.
    Desselberger U, Iturriza-Gomara M, Gray JJ (2001) Rotavirus epidemiology and surveillance. In: Gastroenteritis Viruses. Novartis Foundation Symposium 238. John Wiley and Sons, Ltd, London, 125–152CrossRefGoogle Scholar
  37. 37.
    Santos N, Hoshino Y (2005) Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15: 29–56CrossRefPubMedGoogle Scholar
  38. 38.
    Gentsch JR, Laird AR, Bielfelt B, Griffin DD, Banyai K, Ramachandran M, Jain V, Cunliffe NA, Nakagomi O, Kirkwood CD et al (2005) Serotype diversity and reassortment between human and animal rotavirus strains: Implications for rotavirus vaccine programmes. J Infect Dis 192: S146–S159CrossRefPubMedGoogle Scholar
  39. 39.
    Gouvea V, de Castro L, Timenetsky MC, Greeneberg HB, Santos N (1994) Rotavirus serotype G5 associated with diarrhea in Brazilian children. J Clin Microbiol 32: 1408–1409PubMedGoogle Scholar
  40. 40.
    Santos N, Lima RCC, Pereira CFA, Gouvea V (1998) Detection of rotavirus types G8 and G10 among Brazilian children with diarrhea. J Clin Microbiol 36: 2727–2729PubMedGoogle Scholar
  41. 41.
    Armah GE, Pager CT, Asmah RH, Anto FR, Oduro AR, Binka FN, Steele AD (2001) Prevalence of unusual human rotavirus strains in Ghanaian children. J Med Virol 63: 67–71CrossRefPubMedGoogle Scholar
  42. 42.
    Cunliffe NA, Gondwe JS, Broadhead RL, Molyneaux ME, Woods PA, Bresee JS, Glass RI, Gentsch JE, Hart CA (1999) Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi from 1997 to 1998. Predominance of novel P[6]G8 strains. J Med Virol 57: 308–312CrossRefPubMedGoogle Scholar
  43. 43.
    Matthijnssens J, Rahman M, Yang X, Delbeke T, Arijs I, Kabue JP, Muyemba JT, van Ranst M (2006) G8 rotavirus strains isolated in the Democratic Republic of Congo belong to the DS-1 like genogroup. J Clin Microbiol 44: 1801–1809CrossRefPubMedGoogle Scholar
  44. 44.
    Das S, Gentsch JR, Cicirello HG, Woods PA, Gupta A, Ramachandran M, Kumar R, Bhan MK, Glass RI (1994) Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol 32: 1820–1822PubMedGoogle Scholar
  45. 45.
    Offit PA, Blavat G (1986) Identification of the two rotavirus genes determining neutralization specificities. J Virol 57: 376–378PubMedGoogle Scholar
  46. 46.
    Rao CD, Gowda K, Reddy BSY (2001) Sequence analysis of theVP4 and VP7 genes of non-typeable strains identifies a new pair of outer capsid proteins representing novel P and G genotypes in bovine rotaviruses. Virology 276: 104–113CrossRefGoogle Scholar
  47. 47.
    Iturriza-Gomara M, Isherwood B, Desselberger U, Gray JJ (2001) Reassortment in vivo. A driving force for diversity of human rotavirus strains isolated in the UK between 1995 and 1999. J Virol 75: 3696–3705CrossRefPubMedGoogle Scholar
  48. 48.
    Bishop RF, Davidson GP, Holmes IH, Ruck BJ (1973) Virus particles in epithelial cells of duodenal mucosa of children with gastroenteritis. Lancet 2: 1281–1283CrossRefPubMedGoogle Scholar
  49. 49.
    Flewett TH, Davies HA, Bryden AS, Robertson MJ (1974) Diagnostic electron microscopy of faeces II. Acute gastroenteritis associated with reovirus-like particles. J Clin Pathol 27: 608–614CrossRefPubMedGoogle Scholar
  50. 50.
    Ansari SA, Springthorpe VS, Sattar SA (1991) Survival and vehicular spread of human rotaviruses. Possible relation to seasonality of outbreaks. Rev Infect Dis 13: 488–491Google Scholar
  51. 51.
    Santosham M, Yolken RH, Quiroz E, Dillman L, Oro G, Reeves WC, Sack RB (1983) Detection of rotavirus in respiratory secretions of children with pneumonia. J Pediatr 103: 583–585CrossRefPubMedGoogle Scholar
  52. 52.
    Zheng BJ, Chang RX, Ma GZ, Xie JM, Liu Q, Liu XR, Ng MH (1991) Rotavirus infection of the oropharynx and respiratory in young children. J Med Virol 34: 29–37CrossRefPubMedGoogle Scholar
  53. 53.
    Rodriguez W, Kim H, Arrobio J, Brandt CD, Chanock RM, Kapikian AZ, Wyatt RG, Parrott RH (1977) Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and children. J Pediatr 91: 188–193CrossRefPubMedGoogle Scholar
  54. 54.
    Staat MA, Azimi PH, Berke T, Roberts N, Bernstein DI, Ward RL, Pickering LK, Matson DO (2002) Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J 21: 221–227CrossRefPubMedGoogle Scholar
  55. 55.
    Holmes IH, Ruck BJ, Bishop RF, Davidson GP (1975) Infantile enteritis viruses: Morphogenesis and morphology. J Virol 16: 937–943Google Scholar
  56. 56.
    Midthun K, Kapikian AZ (1996) Rotavirus vaccines: An overview. Clin Microbiol Rev 9: 423–434PubMedGoogle Scholar
  57. 57.
    Gorrell RJ, Bishop RF (1999) Homotypic and heterotypic serum neutralising antibody response to rotavirus proteins following natural primary infection and re-infection in children. J Med Virol 59: 204–211CrossRefGoogle Scholar
  58. 58.
    Ward RL, Bernstein DI (1994) Protection against rotavirus disease after natural infection. J Infect Dis 169: 900–904PubMedGoogle Scholar
  59. 59.
    Clark HF, Offit PA, Ellis RW, Eiden JJ, Krah D, Shaw AR, Pichichero M, Treanor JJ, Borian FE, Bell LM, Plotkin SA (1996) The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis 174S: s73–80Google Scholar
  60. 60.
    Jiang B, Gentsch JR, Glass RI (2002) The role of serum antibodies in the protection against rotavirus disease: An overview. Clin Infect Dis 34: 1351–1361CrossRefPubMedGoogle Scholar
  61. 61.
    Hjelt K, Grauballe PC, Paerregaard A, Nielsen OH, Krasilnikoff PA (1987) Protective efficacy of pre-existing rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children. J Med Virol 21: 39–47CrossRefPubMedGoogle Scholar
  62. 62.
    Clemens JD, Ward RL, Rao MR, Sack DA, Knowlton DR, van Loon FP, Huda S, McNeal M, Ahmed F, Schiff G (1992) Sero-epidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh. J Infect Dis 165: 161–165PubMedGoogle Scholar
  63. 63.
    Bernstein DI, Smith VE, Sander DS, Pax KA, Schiff GM, Ward RL (1990) Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis 162: 1055–1062PubMedGoogle Scholar
  64. 64.
    Kapikian AZ, Hoshino Y, Chanock RM, Perez-Schael I (1996) Efficacy of a quadrivalent rhesus rotavirus-based vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis 174S: s65–s72Google Scholar
  65. 65.
    Offit PA, Hoffenberg EJ, Santos N, Gouvea V (1993) Rotavirus-specific humoral and cellular immune response after primary symptomatic infection. J Infect Dis 167: 1436–1440PubMedGoogle Scholar
  66. 66.
    Jaimes MC, Rojas OL, Gonzalez AM, Cajiao I, Charpilienne A, Pothier P, Kohli E, Greenberg HB, Franco MA, Angel J (2002) Frequencies of virus-specific CD4 and CD8 T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults. J Virol 76: 4741–4749CrossRefPubMedGoogle Scholar
  67. 67.
    Ward RL (2003) Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol 2003; 6: 17–24CrossRefGoogle Scholar
  68. 68.
    Heaton PM, Gouveia MG, Miller JM, Offit P, Clark HF (2005) Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis. J Infect Dis 192: S17–S21CrossRefPubMedGoogle Scholar
  69. 69.
    Clark HF, Offit PA, Plotkin SA, Heaton PM (2006) The new pentavalent rotavirus vaccine composed of bovine (strain WC3) human rotavirus reassortants. Pediatr Infect Dis J 25: 577–583CrossRefPubMedGoogle Scholar
  70. 70.
    Bernstein DI, Sander DS, Smith VE, Schiff GM, Ward RL (1991) Protection from rotavirus re-infection. Two year prospective study. J Infect Dis 164: 277–283PubMedGoogle Scholar
  71. 71.
    Estes MK, Graham DY (1985) Rotavirus antigens. Adv Exp Med Biol 185: 201–214PubMedGoogle Scholar
  72. 72.
    Woode GN, Crouch CF (1978) Naturally occurring and experimentally induced rotaviral infections of domestic and laboratory animals. J Am Vet Med Assoc 173: 522–526PubMedGoogle Scholar
  73. 73.
    Bresee JS, Parashar U, Widdowson MA, Gentsch JR, Steele AD, Glass RI (2005) Update on rotavirus vaccines. Pediatr Infect Dis J 24: 947–952CrossRefPubMedGoogle Scholar
  74. 74.
    Christy C, Madore HP, Treanor JJ, Pray K, Kapikian AZ, Chanock RM, Dolin R (1986) Safety and reactogenicity of the live attenuated rhesus monkey rotavirus vaccine. J Infect Dis 154: 1045–1047PubMedGoogle Scholar
  75. 75.
    Flores J, Perez-Schael I, Gonzalez M, Garcia D, Perez M, Daoud N, Cunot W, Kapikian AZ (1987) Protection against severe rotavirus diarrhea by rhesus rotavirus vaccine in Venezuelan infants. Lancet 1: 882–884CrossRefPubMedGoogle Scholar
  76. 76.
    Santosham M, Letson GW, Wolff M, Reid R, Gahagan S, Adams R, Callahan C, Sack RB, Kapikian AZ (1991) A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis 163: 483–487PubMedGoogle Scholar
  77. 77.
    Hanlon P, Hanlon L, Marsh V, Byass P, Shenton F, Hassan-King M, Jobe O, Sillah H, Hayes R, M’Boge BH et al (1987) Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1: 1342–1345CrossRefPubMedGoogle Scholar
  78. 78.
    Lanata C, Black RE, del Aguila R, Gil A, Verastegui H, Gerna G, Flores J, Kapikian AZ, Andre FE (1989) Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two or three doses of the RIT4237 attenuated bovine rotavirus vaccine. J Infect Dis 159: 452–459PubMedGoogle Scholar
  79. 79.
    Georges-Courbot MC, Monges J, Siopathis MR, Roungou JB, Gresenguet G, Bellec L, Bouquety JC, Lanckriet C, Cadoz M, Hessel L et al (1991) Evaluation of the efficacy of a low passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 142: 405–411CrossRefPubMedGoogle Scholar
  80. 80.
    Midthun K, Greenberg HB, Hoshino Y, Kapikian AZ, Wyatt RG, Chanock RM (1985) Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol 53: 949–954PubMedGoogle Scholar
  81. 81.
    Vesikari T, Green KY, Flores J, Kapikian AZ (1992) Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus reassortant rotavirus vaccines with human rotavirus VP7 serotype specificity. Pediatr Infect Dis J 11: 535–542PubMedCrossRefGoogle Scholar
  82. 82.
    Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, Mack ME, Davidson BL, Kapikian AZ (1996) Safety and efficacy of the high dose rhesus-human reassortant rotavirus vaccines: Report of the national multi-centre trial. Pediatrics 97: 7–13PubMedGoogle Scholar
  83. 83.
    Perez-Schael I, Guntinas MJ, Perez M, Pagone V, Rojas AM, Gonzalez R, Cunto W, Kapikian AZ (1997) Efficacy of the rhesus rotavirus based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 337: 1181–1187CrossRefPubMedGoogle Scholar
  84. 84.
    Joensuu J, Koskenniemi E, Pang XL, Vesikari T (1997) Randomised placebo controlled trial of the rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 350: 1205–1209CrossRefPubMedGoogle Scholar
  85. 85.
    Centers for Disease Control and Prevention (1999) Rotavirus vaccines for the prevention of rotavirus gastroenteritis among children — Recommendations of the Advisory Committee on Immunization Practices. MMWR 48: 1–23Google Scholar
  86. 86.
    Centers for Disease Control and Prevention (1999) Intussusception among recipients of rotavirus vaccine — United States 1998–1999. MMWR 48: 577–581Google Scholar
  87. 87.
    Bresee JS, El Arifeen S, Azim T, Chakraborty J, Mounts AW, Podde G, Gentsch JR, Ward RL, Black R, Glass RI, Yunus M (2001) Safety and immunogenicity of tetravalent rhesus based rotavirus vaccine in Bangladesh. Pediatric Infect Dis J 20: 1136–1143CrossRefGoogle Scholar
  88. 88.
    Simonsen L, Morens DM, Elixhauser A, Gerber M, van Raden M, Blackwelder WC (2001) Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet 358: 1224–1227CrossRefPubMedGoogle Scholar
  89. 89.
    Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ (2005) More on RotaShield and intussusception: The role of age at the time of vaccination. J Infect Dis 192: S36–S43CrossRefPubMedGoogle Scholar
  90. 90.
    World Health Organization (2006) Report of the WHO Global Advisory Committee on Vaccine Safety. Wkly Epidemiol Rec 81: 15–17Google Scholar
  91. 91.
    Clark HF, White CJ, Offit PA, Ellis RW, Krah D, Shaw AR, Eiden JJ, Pichich M, Treanor JJ (1995) Preliminary evaluation of safety and efficacy of quadrivalent human-bovine reassortant rotavirus vaccine. Pediatr Res 37: 172Google Scholar
  92. 92.
    Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ et al (2004) Safety, efficacy and immunogenicity of a live quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 144: 184–190CrossRefPubMedGoogle Scholar
  93. 93.
    Clark HF, Furukawa F, Bell LM, Offit PA, Perella PA, Plotkin SA (1986) Immune response of infants and children to low passage bovine rotavirus (strain WC3). Am J Dis Child 140: 350–355PubMedGoogle Scholar
  94. 94.
    Clark HF, Borian FE, Plotkin SA (1990) Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. J Infect Dis 161: 1099–1104PubMedGoogle Scholar
  95. 95.
    Hoshino Y, Jones RW, Chanock RM, Kapikian AZ (1997) Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates. J Med Virol 51: 319–325CrossRefPubMedGoogle Scholar
  96. 96.
    Clements-Mann ML, Makhene MK, Mrukowicz J, Wright PF, Hoshino Y, Midthun K, Sperber E, Karron R, Kapikian AZ (1999) Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3, or 4 in adults, children and infants. Vaccine 17: 2715–2725CrossRefPubMedGoogle Scholar
  97. 97.
    Clements-Mann ML, Dudas R, Hoshino Y, Nehring P, Sperber E, Wagner M, Stephens I, Karron R, Deforest A, Kapikian AZ (2001) Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants. Vaccine 19: 4676–4684CrossRefPubMedGoogle Scholar
  98. 98.
    Bernstein DI, Smith VE, Sherwood JR, Schiff GM, Sander DS, deFeudis D, Spriggs DR, Ward RL (1998) Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine 16: 381–387CrossRefPubMedGoogle Scholar
  99. 99.
    Bernstein DI, Sack DA, Rothstein E, Reisinger K, Smith VE, O’Sullivan D, Spriggs DR, Ward RL (1999) Efficacy of live, attenuated human rotavirus vaccine 89-12 in infants: A randomised placebo-controlled trial. Lancet 354: 287–290CrossRefPubMedGoogle Scholar
  100. 100.
    Bernstein DI, Sack DA, Reisinger K, Rothstien E, Ward RL (2002) Second year follow-up evaluation of live, attenuated human rotavirus 89-12 vaccine in healthy infants. J Infect Dis 186: 1487–1489CrossRefPubMedGoogle Scholar
  101. 101.
    De Vos B, Vesikari T, Linhares A, Salinas B, Perez-Schael I, Ruiz-Palacois G, Guerro MdL, Phua KB, Delem A, Hardt K (2004) A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J 23: S179–S182CrossRefPubMedGoogle Scholar
  102. 102.
    Vesikari T, Karvonen A, Korhonen T, Espo M, LeBacq E, Forster J, Zepp F, Delem A, De Vos B (2004) Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine 22: 2836–2842CrossRefPubMedGoogle Scholar
  103. 103.
    Salinas B, Perez-Schael I, Linhares A, Ruiz-Palacios GM, Guerrero MdL, Yarzabal JP, Cervantes Y, Costa Clemens SA, Damaso S, Hardt K, DE Vos B (2005) Evaluation of the safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414. Pediatr Infect Dis J 24: 807–816CrossRefPubMedGoogle Scholar
  104. 104.
    Phua KB, Quak SH, Lee BW, Emmanual SC, Goh P, Han HH, De Vos B, Bock HL (2005) Evaluation of RIX4414, a live attenuated rotavirus vaccine in a randomized double-blind, placebo-controlled, phase II trial involving 2464 Singaporean infants. J Infect Dis 192: S6–S16CrossRefPubMedGoogle Scholar
  105. 105.
    Zaman K, Sack DA, Yunus M, Arifeen SE, Azim T, Podder G, Faruque ASG, Karim S, Luby S, Breiman RF. Rotavirus vaccine trials in Bangladesh. 8th Commonwealth Congress on Diarrhea and Malnutrition, 6–8 February 2006. Dhaka, BangladeshGoogle Scholar
  106. 106.
    Steele AD, Tumbo JM, Armah GE, Reynders J, Scholtz F, Bos P, de Beer MC, van der Merwe CF, Delem A, De Vos B (2004) Immunogenicity and reactogenicity of a new live attenuated oral rotavirus vaccine (RIX4414) when administered concurrently with poliovirus vaccines in African infants. International Congress of Paediatrics, 15–20 August, 2004. Cancun, MexicoGoogle Scholar
  107. 107.
    Steele AD, Tumbo JM, Reynders J, Scholtz F, Bos P, de Beer MC, van der Merwe CF, Delem A, De Vos B (2006) Comparison of two different regimens (two doses versus three doses) in terms of reactogenicity and immunogenicity of the live attenuated human rotavirus vaccine RIX4414 in South African infants. 11th Asian Conference on Diarrhea Disease and Nutrition. 8–10 March, 2006, Bangkok, ThailandGoogle Scholar
  108. 108.
    Barnes GL, Lund JS, Adams L, Mora A, Mitchell SV, Caples A, Bishop RF (1997) Phase I trial of a candidate rotavirus vaccine (RV3) derived from a human neonate. J Paediatr Child Health 33: 300–304PubMedGoogle Scholar
  109. 109.
    Barnes GL, Lund JS, Mitchell SV, de Bruyn L, Piggford L, Smith AL, Furmedge J, Masendycz PJ, Bugg HC, Bogdanovic-Sakran N et al (2002) Early phase II trial of human rotavirus vaccine candidate RV3. Vaccine 20: 2950–2956CrossRefPubMedGoogle Scholar
  110. 110.
    Glass RI, Bhan MK, Ray P, Bahl R, Parashar U, Greenberg HB, Rao CD, Bhandari N, Maldonado Y, Ward RL et al (2005) Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis 192: S30–S35CrossRefPubMedGoogle Scholar
  111. 111.
    Glass RI, Bresee JS, Turcois R, Fischer TK, Parashar U, Steele AD (2005) Rotavirus vaccines: Targeting the developing world. J Infect Dis 192: S160–S166CrossRefPubMedGoogle Scholar
  112. 112.
    World Health Organization (2006) Report of the WHO Strategic Advisory Group of Experts (SAGE). Wkly Epidemiol Rec 81: 8–9Google Scholar
  113. 113.
    Linhares AC, Carmoi KB, Oliveira KK, Freitas RB, Bellesi N, Monteiro TAF, Gabbay YB, Mascarehas JD (2002) Nutritional status in relation to the efficacy of the rhesus human reassortant tetravalent rotavirus vaccine (RRV-TV) in infants in Belem, Para State, Brazil. Rev Inst Med trop S Paulo 44: 13–16CrossRefPubMedGoogle Scholar
  114. 114.
    Perez-Schael I, Salinas B, Tomat M, Linhares AC, Ruiz-Palacios GM, Guerrero ML, Costa-Clemens SA, Bouckenooghe A, Yarzabal JP. Human rotavirus vaccine RIX4414 is efficacious in malnourished children. 9th International Symposium on Double-stranded RNA viruses, 21–26 October, 2006. Cape Town, South AfricaGoogle Scholar
  115. 115.
    Migasena S, Simasathien S, Samakoses R, Pitisuttitham, Sangaroon P, van Steenis G, Beuvery EC, Bugg H, Bishop RF, Davidson BL, Vesikari T (1995) Simultaneous administration of oral rhesus human reassortant tetravalent human rotavirus (RRV-TV) and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 13: 168–174CrossRefPubMedGoogle Scholar
  116. 116.
    Murphy BR, Morens DM, Simonsen L, Chanock RM, La Montagne JR, Kapikian AZ (2003) Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J Infect Dis 187: 1301–1308CrossRefPubMedGoogle Scholar
  117. 117.
    Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW et al (2001) Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 344: 564–572CrossRefPubMedGoogle Scholar
  118. 118.
    Podewils LJ, Antil L, Hummelman E, Bresee JS, Parashar U, Rheingans R (2005) Projected cost effectiveness of rotavirus vaccination in Asia. J Infect Dis 192: S133–S145CrossRefPubMedGoogle Scholar
  119. 119.
    Walker DG and Rheingans R (2005) Cost-effectiveness of rotavirus vaccines. Expert Rev Pharmaco-economics Outcomes Res 5: 593–601CrossRefGoogle Scholar
  120. 120.
    World Health Organization (2006) Report of a WHO Meeting on the cost estimation and cost effectiveness of rotavirus vaccines. Wkly Epidemiol Rec 81: 350–353Google Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2007

Authors and Affiliations

  • Duncan Steele
    • 1
  1. 1.Initiative for Vaccine Research, Department of Immunization, Vaccines and BiologicalsWorld Health OrganizationGenevaSwitzerland

Personalised recommendations